The PGY1 Pharmacy Residency with Geisinger Ambulatory Clinical Pharmacy Programs (Geisinger Clinics West) in State College, Pa., has an accreditation pre-candidate status with American Society of Health-System Pharmacists (ASHP). The residency offers customized residency education to successfully prepare clinical pharmacists to care for patients in an ambulatory care setting. Residents will innovate, lead and improve the quality of care for patients at Geisinger. Residents are immersed in a collaborative interprofessional culture where clinical pharmacists practice at the top of their license in acute care, ambulatory care, specialty pharmacy and research. Each individual resident’s curriculum is customized to facilitate achievement of their personal and professional goals.
As a PGY-1 pharmacy resident in a primary care clinic setting, you will provide quality pharmaceutical care by implementing safe, efficacious and cost-effective drug therapy regimens for all patients. The pharmacy resident will work in a multidisciplinary practice and collaborate with all team members utilizing collaborative practice agreements. With a focus on primary care, the residents are responsible for Medication Therapy Disease Management (MTDM) activities related to anticoagulation therapy, diabetes (including insulin pump management), hypertension, dyslipidemia, asthma, heart failure, osteoporosis, COPD, pain management, and more. Upon establishing competency in specific disease states, the resident will provide face-to-face and one-on-one phone-based medication management for patients with chronic diseases. In addition to patient care activities, the resident will provide assistance and in-depth drug information to healthcare personnel.
Our goal is to provide each resident an exceptional training experience to foster the development of their professional expertise and competence as a clinical pharmacist in primary care. The pharmacists at Geisinger are committed to delivering the highest quality of patient care and pharmacy education.
The Geisinger Clinics West PGY-1 Pharmacy Residency participates in the ASHP Resident Matching Program as well as the Pharmacy Online Residency Centralized Application Service (PhORCAS). Applicants should submit the following materials via Phorcas:
Letter of intent outlining career objectives
Academic (school of pharmacy) transcripts
Three letters of recommendation
Also required are a PharmD or equivalent degree (from an ACPE-accredited school or college) and to be licensed or eligible for licensure in the Commonwealth of Pennsylvania.
The deadline for application is Jan. 1, 2021.
About Geisinger Clinics West PGY1 Residency Program in Ambulatory Setting
The Geisinger Ambulatory Clinical Pharmacy program has more than 90 ambulatory clinical pharmacists managing patients’ medications for over 20 medical conditions. Pharmacists are incorporated into both Geisinger-owned PCMH and ACO sites within four practice models: primary care disease management, specialty medicine disease management, home-based primary care and pharmacy telemanagement. The Medication Therapy Disease Management program was named the recipient of the ASHP Award of Excellence for 2016 and a finalist in Medication Safety for chronic pain management.
The primary care pharmacists are embedded within family practice and internal medicine sites across the health system. This practice model is based on a concept of comprehensive, high-value, office-based visits to achieve ongoing management and patient ownership of chronic disease patients at primary care sites. These pharmacists help to improve medication-related patient outcomes and assist primary care providers in decreasing healthcare costs and meeting quality benchmarks. Under collaborative practice agreements with providers, the pharmacists perform comprehensive medication reviews and medication reconciliation, ...identify and resolve medication-related problems, manage chronic disease states through evaluation of the safety and effectiveness of medication regimens (including titration and monitoring towards targeted patient outcomes), design patient-centered, cost-effective medication regimens, optimize polypharmacy and provide education to patients and providers.